Volume 6, Issue 5, Pages (May 2016)

Slides:



Advertisements
Similar presentations
Volume 8, Issue 5, Pages (May 2017)
Advertisements

Down-regulation of MicroRNA-31 in CD4+ T Cells Contributes to Immunosuppression in Human Sepsis by Promoting TH2 Skewing Anesthes. 2016;124(4):
GCN5 Regulates FGF Signaling and Activates Selective MYC Target Genes during Early Embryoid Body Differentiation  Li Wang, Evangelia Koutelou, Calley.
Volume 80, Issue 4, Pages (August 2011)
Volume 14, Issue 1, Pages (January 2014)
Volume 17, Issue 12, Pages (December 2016)
Volume 18, Issue 12, Pages (March 2017)
Volume 146, Issue 7, Pages e5 (June 2014)
Experimental Hematology
Volume 11, Issue 2, Pages (August 2012)
Embryonic stem cell–derived hemangioblasts remain epigenetically plastic and require PRC1 to prevent neural gene expression by Luca Mazzarella, Helle F.
Roger B. Deal, Steven Henikoff  Developmental Cell 
Volume 7, Issue 1, Pages (July 2010)
Volume 38, Issue 5, Pages (June 2010)
Volume 23, Issue 5, Pages (May 2018)
Volume 9, Issue 6, Pages (December 2017)
Volume 7, Issue 5, Pages (June 2014)
Volume 17, Issue 6, Pages (December 2015)
Volume 17, Issue 4, Pages (October 2015)
Volume 21, Issue 5, Pages e7 (November 2017)
Volume 60, Issue 4, Pages (November 2015)
Volume 11, Issue 6, Pages (June 2007)
Volume 9, Issue 3, Pages (September 2017)
Volume 139, Issue 1, Pages (July 2010)
Volume 65, Issue 4, Pages e9 (February 2017)
Volume 23, Issue 10, Pages (October 2016)
Volume 32, Issue 4, Pages (November 2008)
Volume 10, Issue 1, Pages (January 2018)
Volume 11, Issue 3, Pages (April 2015)
Volume 55, Issue 3, Pages (August 2014)
Volume 20, Issue 5, Pages (November 2016)
Molecular Mechanisms Regulating the Defects in Fragile X Syndrome Neurons Derived from Human Pluripotent Stem Cells  Tomer Halevy, Christian Czech, Nissim.
Volume 7, Issue 6, Pages (June 2014)
Volume 67, Issue 6, Pages e6 (September 2017)
Volume 19, Issue 1, Pages (January 2014)
Wei Jiang, Yuting Liu, Rui Liu, Kun Zhang, Yi Zhang  Cell Reports 
Expression of Alternative Ago2 Isoform Associated with Loss of microRNA-Driven Translational Repression in Mouse Oocytes  Jacob W. Freimer, Raga Krishnakumar,
Volume 10, Issue 3, Pages (March 2018)
Volume 9, Issue 5, Pages (November 2017)
Volume 64, Issue 6, Pages (December 2016)
Volume 5, Issue 5, Pages (November 2015)
Volume 54, Issue 5, Pages (June 2014)
Volume 6, Issue 2, Pages (February 2010)
Volume 8, Issue 5, Pages (May 2017)
Volume 10, Issue 10, Pages (October 2017)
Volume 132, Issue 6, Pages (March 2008)
Alterations in mRNA 3′ UTR Isoform Abundance Accompany Gene Expression Changes in Human Huntington’s Disease Brains  Lindsay Romo, Ami Ashar-Patel, Edith.
An RNAi Screen of Chromatin Proteins Identifies Tip60-p400 as a Regulator of Embryonic Stem Cell Identity  Thomas G. Fazzio, Jason T. Huff, Barbara Panning 
Volume 14, Issue 5, Pages (February 2016)
Volume 39, Issue 5, Pages (November 2013)
Volume 35, Issue 2, Pages (August 2011)
Xudong Wu, Jens Vilstrup Johansen, Kristian Helin  Molecular Cell 
Volume 6, Issue 5, Pages (May 2016)
Volume 8, Issue 4, Pages (April 2017)
Volume 57, Issue 4, Pages (February 2015)
Xuepei Lei, Jianwei Jiao  Stem Cell Reports 
Volume 63, Issue 3, Pages (August 2016)
Volume 7, Issue 2, Pages (August 2010)
Volume 5, Issue 6, Pages (December 2015)
Negative Regulation of Tumor Suppressor p53 by MicroRNA miR-504
Short Telomeres in ESCs Lead to Unstable Differentiation
Volume 1, Issue 3, Pages (September 2007)
Volume 6, Issue 3, Pages (March 2016)
CNOT3-Dependent mRNA Deadenylation Safeguards the Pluripotent State
Volume 9, Issue 5, Pages (November 2017)
Volume 17, Issue 3, Pages (October 2016)
Volume 24, Issue 8, Pages e7 (August 2018)
EZH2 overexpression establishes a unique and conserved super-enhancer–associated transcriptional landscape. EZH2 overexpression establishes a unique and.
A Splicing-Independent Function of SF2/ASF in MicroRNA Processing
Global Splicing Pattern Reversion during Somatic Cell Reprogramming
Presentation transcript:

Volume 6, Issue 5, Pages 635-642 (May 2016) MicroRNAs of the miR-290–295 Family Maintain Bivalency in Mouse Embryonic Stem Cells  Bryony Graham, Antoine Marcais, Gopuraja Dharmalingam, Thomas Carroll, Chryssa Kanellopoulou, Johannes Graumann, Tatyana B. Nesterova, Anna Bermange, Pijus Brazauskas, Barbara Xella, Skirmantas Kriaucionis, Douglas R. Higgs, Neil Brockdorff, Matthias Mann, Amanda G. Fisher, Matthias Merkenschlager  Stem Cell Reports  Volume 6, Issue 5, Pages 635-642 (May 2016) DOI: 10.1016/j.stemcr.2016.03.005 Copyright © 2016 International Society for Stem Cell Research Terms and Conditions

Figure 1 DICER Maintains the Association of the Core PRC2 Component EZH2 with Many Bivalent Genes in ESCs (A) EZH2 occupancy at transcriptional start sites of bivalent genes and numbers of EZH2-peaked bivalent genes that were retained (gray) or lost (orange) in Dicer-deficient ESCs. See Figure 4A for a complementary analysis of SUZ12 binding. (B) ChIP-seq track of the Pax6 locus with highlighted EZH2 peak. (C) ChIP-PCR of EZH2 (top), H3K27me3 (middle), and H3K4me3 (bottom) at selected genomic sites. Mean ± SD of three independent experiments. ∗p < 0.05 between control and Dicer-deficient cells. EZH2 enrichment is relative to input; H3K27me3 and H3K4me3 are relative to H3. (D) Time-course analysis of Dicer deletion and loss of the miRNAs miR-291a-3p and miR-92 in Dicerlox/lox ERt2Cre ESCs treated with carrier (EtOH) or 4-OHT. Expression of Dicer mRNA is shown relative to Hprt; expression of miRNAs is shown relative to snoRNA-135. Mean ± SD of three independent experiments. ∗p < 0.05 (t test) between day 0 and the time points indicated. (E) EZH2 occupancy of formerly bivalent gene promoters within 8 days of ERt2Cre activation. Mean ± SD of three independent experiments. ∗p < 0.05 (t test) between untreated cells (day 0) and cells treated with either EtOH or 4-OHT. Stem Cell Reports 2016 6, 635-642DOI: (10.1016/j.stemcr.2016.03.005) Copyright © 2016 International Society for Stem Cell Research Terms and Conditions

Figure 2 Dicer Deletion Does Not Diminish the Expression of PcG Proteins, the Association of EZH2 with Chromatin, or Global DNA Methylation in ESCs (A) qRT-PCR of the PRC2 components Ezh2, Suz1, Eed, and Jarid2. Mean ± SD of three independent experiments. ∗p < 0.05 (t test) between control and Dicer-deficient cells. (B) Immunoblots of the PRC2 components EZH2, SUZ12, EED, and JARID2 and the histone modifications H3K4me3 and H3K27me3 in control and Dicer-deficient ESCs. Left: representative blots. Right: densitometry readings of three independent experiments; ∗p < 0.05. DICER protein is a control. (C) Immunoblots of cytoplasmic (Cy), nuclear soluble (Nu) and chromatin-associated (Ch) fractions of control and Dicer-deficient ESCs. Histone H3 identifies the chromatin fraction. (D) ERT2Cre Dicerlox/lox ESCs were treated with either 4-OHT or carrier control (EtOH) and the fraction of methylated cytosine residues was followed by high-performance liquid chromatography. See also Figure S1. Stem Cell Reports 2016 6, 635-642DOI: (10.1016/j.stemcr.2016.03.005) Copyright © 2016 International Society for Stem Cell Research Terms and Conditions

Figure 3 Accumulation of Spliced and Unspliced Transcripts and Proteins from Formerly Bivalent Genes in Dicer-Deficient ESCs (A) Gene-expression profiles of Dicer-deficient ESCs were examined by miReduce for 3′ UTR sequence motif enrichment. (B) GSEA of bivalent genes compared with miR-290 targets. FDR, false discovery rate; NES, normalized enrichment score. (C) GSEA results for eight sets of developmentally regulated genes. Developmentally regulated genes were separated into bivalent and non-bivalent. FDR, false discovery rate; NES, normalized enrichment score. (D) PCR strategy to distinguish primary (unspliced) from mature (spliced) transcripts. (E) qRT-PCR analysis of primary transcripts (blue bars) and mature transcripts (red bars) in response to inducible ERt2Cre activation in Dicerlox/lox ESCs by 4-OHT. Black bars represent data for EtOH-treated control cells. Mean ± SD of three independent experiments. Expression is shown relative to Ubc, Hprt, and Rn18s. ∗p < 0.05 (t test). (F) The relationship between changes in gene expression and EZH2 occupancy in Dicer-deficient ESCs. Orange shading indicates loss of EZH2 relative to increased global transcript levels (p < 10−8; left). This association was strongest for bivalent genes (p < 10−11; right). Gray shading indicates no significant association. (G) SILAC quantified 3,431 protein groups, of which 169 (4.9%) were significantly upregulated and 95 (2.8%) significantly downregulated in Dicer-deficient ESCs (left). Of 62 proteins encoded by bivalent genes, 14 (23%) were upregulated and 2 (3%) downregulated (right). Proteins from bivalent genes were more likely to be deregulated than proteins from non-bivalent genes (odds ratio = 4.17). The odds for up- versus downregulation were 0.56 for all proteins and 0.14 for proteins from bivalent genes (odds ratio = 3.93). See also Figures S2 and S3. Stem Cell Reports 2016 6, 635-642DOI: (10.1016/j.stemcr.2016.03.005) Copyright © 2016 International Society for Stem Cell Research Terms and Conditions

Figure 4 miRNAs Rescue PRC2 Binding to Formerly Bivalent Promoters in Dicer-Deficient ESCs (A) SUZ12 occupancy at transcriptional start sites of bivalent genes in control (black) and Dicer-deficient ESCs (red) in serum + LIF. 968 of 2,074 bivalent genes (46.7%) and 366 of 15,850 non-bivalent genes (2.3%) showed reduced SUZ12 binding in Dicer-deficient ESCs (p < 10−300). (B) Control or Dicer-deficient ESCs were transfected with miR-294, a member of the ESC miRNA family miR-290–295. ChIP for the PRC2 core component EZH2 was done 2 days later and analyzed by real-time PCR (mean ± SE of two independent experiments). Stem Cell Reports 2016 6, 635-642DOI: (10.1016/j.stemcr.2016.03.005) Copyright © 2016 International Society for Stem Cell Research Terms and Conditions